Daily SPAC Update – Jan 26, 2024

by | Jan 26, 2024

Daily SPAC Update for Jan 26, 2024. NSTB settles with SEC; decides to liquidate. NCAC deSPACs as Psyence Group (PBM). JWSM and CSTAF adjourn extensions.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha SPAC Intelligence Platform (7-Day Trial)

SEC APPROVES FINAL RULES

For most, the SPAC boom is long-dead and was unlikely to ever return to the levels of irrational exuberance seen during peak times. Still, the SEC has long wanted to layer on additional regulation to ensure that it doesn’t happen. On Jan 24 the SEC commission, chaired by Gary Gensler, voted 3-2 to adopt the new rules which will make SPACs feel a lot more like traditional IPOs. For more on the new rules and the market’s reaction, below are some good reads.

Daily SPAC Update

SPAC Insanity: NSTB – Northern Star Investment Corp II
Yesterday was a big, crazy day for NSTB as it settled with the SEC. Decided to liquidate (in part surely to avoid settlement payments to SEC). And, somehow letting holders retain ownership of shares so it can trade on the OTC. Here are the details:

DeSPACs
NCAC -> PBM on Jan 26

OTHER SPAC NEWS
CVII – CHURCHILL CAPITAL CORP VII * Investor Day Deck
NSTB – NORTHERN STAR INVESTMENT CORP II * Liquidation-> 2024-01-28 * trust $10.48
WTMA – WELSBACH TECHNOLOGY METALS ACQUISITION CORP * Entered LOI
EAC – EDIFY ACQUISITION CORP * Extend to Jul 20, 2024 * 67,766 redeemed
KYCH – KEYARCH ACQUISITION CORP * Extend to Jul 27, 2024 * 337,446 redeemed * trust $10.91
JWSM – JAWS MUSTANG ACQUISITION CORP * Extension vote adjourned to Feb 2, 2024
CSTAF – CONSTELLATION ACQUISITION CORP I * Extension vote adjourned to Jan 29, 2024
ADRT – AULT DISRUPTIVE TECHNOLOGIES CORP * Extension Vote Set: Feb 15, 2024 * trust $11.68
DMAQ – DEEP MEDICINE ACQUISITION CORP * Deal Approved * 378,744 redeemed * trust $11.50

EXTENSION VOTES
DMAQ – DEEP MEDICINE ACQUISITION CORP * extend to July 29, 2024

YESTERDAY’S TOP SPAC GAINERS
18.40% ~ $ 5.02 | ATAK – Aurora Technology Acquisition Corp. (Announced)
10.84% ~ $ 9.00 | NUBI – Nubia Brand International Corp. (Announced)
4.28% ~ $ 9.74 | MEAC – Mercury Ecommerce Acquisition Corp (Announced)
2.93% ~ $ 11.26 | GTAC – Global Technology Acquisition Corp. I (Pre-Deal)
1.22% ~ $ 11.65 | BREZ – Breeze Holdings Acquisition Corp (Announced)

YESTERDAY’S TOP SPAC LOSERS
-15.74% ~ $ 4.79 | NCAC – Newcourt Acquisition Corp (Announced)
-11.99% ~ $ 6.90 | QFTA – Quantum FinTech Acquisition Corp (Announced)
-8.71% ~ $ 11.45 | APAC – StoneBridge Acquisition Corp. (Announced)
-8.63% ~ $ 11.75 | OTEC – OceanTech Acquisitions I Corp. (Announced)
-8.49% ~ $ 34.91 | DWAC – Digital World Acquisition Corp. (Announced)

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.